Atlas Trials

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Clinical trial NCT04432597 · COMPLETED

Trial details

NCT number
NCT04432597
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HPV Positive CancerVulvar, Vaginal, Penile, Rectal CancerAnal CancerOropharyngeal CancerCervical Cancer
Start date
2020-08-11
Primary completion
2022-11-22
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.